1 Unfractionated Heparin Market Overview 1.1 Product Overview and Scope of Unfractionated Heparin 1.2 Unfractionated Heparin Segment by Type 1.2.1 Global Unfractionated Heparin Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Bovine 1.2.3 Porcine 1.3 Unfractionated Heparin Segment by Application 1.3.1 Unfractionated Heparin Sales Comparison by Application: (2021-2027) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Global Unfractionated Heparin Market Size Estimates and Forecasts 1.4.1 Global Unfractionated Heparin Revenue 2016-2027 1.4.2 Global Unfractionated Heparin Sales 2016-2027 1.4.3 Unfractionated Heparin Market Size by Region: 2016 Versus 2021 Versus 2027 2 Unfractionated Heparin Market Competition by Manufacturers 2.1 Global Unfractionated Heparin Sales Market Share by Manufacturers (2016-2021) 2.2 Global Unfractionated Heparin Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Unfractionated Heparin Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Unfractionated Heparin Manufacturing Sites, Area Served, Product Type 2.5 Unfractionated Heparin Market Competitive Situation and Trends 2.5.1 Unfractionated Heparin Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Unfractionated Heparin Players Market Share by Revenue 2.5.3 Global Unfractionated Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Unfractionated Heparin Retrospective Market Scenario by Region 3.1 Global Unfractionated Heparin Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Unfractionated Heparin Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Unfractionated Heparin Market Facts & Figures by Country 3.3.1 North America Unfractionated Heparin Sales by Country 3.3.2 North America Unfractionated Heparin Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Unfractionated Heparin Market Facts & Figures by Country 3.4.1 Europe Unfractionated Heparin Sales by Country 3.4.2 Europe Unfractionated Heparin Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Unfractionated Heparin Market Facts & Figures by Region 3.5.1 Asia Pacific Unfractionated Heparin Sales by Region 3.5.2 Asia Pacific Unfractionated Heparin Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Unfractionated Heparin Market Facts & Figures by Country 3.6.1 Latin America Unfractionated Heparin Sales by Country 3.6.2 Latin America Unfractionated Heparin Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Unfractionated Heparin Market Facts & Figures by Country 3.7.1 Middle East and Africa Unfractionated Heparin Sales by Country 3.7.2 Middle East and Africa Unfractionated Heparin Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Unfractionated Heparin Historic Market Analysis by Type 4.1 Global Unfractionated Heparin Sales Market Share by Type (2016-2021) 4.2 Global Unfractionated Heparin Revenue Market Share by Type (2016-2021) 4.3 Global Unfractionated Heparin Price by Type (2016-2021) 5 Global Unfractionated Heparin Historic Market Analysis by Application 5.1 Global Unfractionated Heparin Sales Market Share by Application (2016-2021) 5.2 Global Unfractionated Heparin Revenue Market Share by Application (2016-2021) 5.3 Global Unfractionated Heparin Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Baxter International Inc. 6.1.1 Baxter International Inc. Corporation Information 6.1.2 Baxter International Inc. Description and Business Overview 6.1.3 Baxter International Inc. Unfractionated Heparin Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Baxter International Inc. Product Portfolio 6.1.5 Baxter International Inc. Recent Developments/Updates 6.2 B. Braun Melsungen AG 6.2.1 B. Braun Melsungen AG Corporation Information 6.2.2 B. Braun Melsungen AG Description and Business Overview 6.2.3 B. Braun Melsungen AG Unfractionated Heparin Sales, Revenue and Gross Margin (2016-2021) 6.2.4 B. Braun Melsungen AG Product Portfolio 6.2.5 B. Braun Melsungen AG Recent Developments/Updates 6.3 Fresenius SE & Co. KGaA 6.3.1 Fresenius SE & Co. KGaA Corporation Information 6.3.2 Fresenius SE & Co. KGaA Description and Business Overview 6.3.3 Fresenius SE & Co. KGaA Unfractionated Heparin Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Fresenius SE & Co. KGaA Product Portfolio 6.3.5 Fresenius SE & Co. KGaA Recent Developments/Updates 6.4 LEO Pharma A/S 6.4.1 LEO Pharma A/S Corporation Information 6.4.2 LEO Pharma A/S Description and Business Overview 6.4.3 LEO Pharma A/S Unfractionated Heparin Sales, Revenue and Gross Margin (2016-2021) 6.4.4 LEO Pharma A/S Product Portfolio 6.4.5 LEO Pharma A/S Recent Developments/Updates 6.5 Sagent Pharmaceuticals 6.5.1 Sagent Pharmaceuticals Corporation Information 6.5.2 Sagent Pharmaceuticals Description and Business Overview 6.5.3 Sagent Pharmaceuticals Unfractionated Heparin Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Sagent Pharmaceuticals Product Portfolio 6.5.5 Sagent Pharmaceuticals Recent Developments/Updates 6.6 Pfizer, Inc. 6.6.1 Pfizer, Inc. Corporation Information 6.6.2 Pfizer, Inc. Description and Business Overview 6.6.3 Pfizer, Inc. Unfractionated Heparin Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Pfizer, Inc. Product Portfolio 6.6.5 Pfizer, Inc. Recent Developments/Updates 7 Unfractionated Heparin Manufacturing Cost Analysis 7.1 Unfractionated Heparin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Unfractionated Heparin 7.4 Unfractionated Heparin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Unfractionated Heparin Distributors List 8.3 Unfractionated Heparin Customers 9 Unfractionated Heparin Market Dynamics 9.1 Unfractionated Heparin Industry Trends 9.2 Unfractionated Heparin Growth Drivers 9.3 Unfractionated Heparin Market Challenges 9.4 Unfractionated Heparin Market Restraints 10 Global Market Forecast 10.1 Unfractionated Heparin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Unfractionated Heparin by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Unfractionated Heparin by Type (2022-2027) 10.2 Unfractionated Heparin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Unfractionated Heparin by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Unfractionated Heparin by Application (2022-2027) 10.3 Unfractionated Heparin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Unfractionated Heparin by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Unfractionated Heparin by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Unfractionated Heparin Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Unfractionated Heparin Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Unfractionated Heparin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Unfractionated Heparin Covered in This Study Table 5. Global Unfractionated Heparin Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Unfractionated Heparin Sales Share by Manufacturers (2016-2021) Table 7. Global Unfractionated Heparin Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Unfractionated Heparin Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Unfractionated Heparin Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Unfractionated Heparin Manufacturing Sites and Area Served Table 11. Manufacturers Unfractionated Heparin Product Type Table 12. Global Unfractionated Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Unfractionated Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Unfractionated Heparin as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Unfractionated Heparin Sales by Region (2016-2021) & (K MT) Table 16. Global Unfractionated Heparin Sales Market Share by Region (2016-2021) Table 17. Global Unfractionated Heparin Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Unfractionated Heparin Sales by Country (2016-2021) & (K MT) Table 19. North America Unfractionated Heparin Sales Market Share by Country (2016-2021) Table 20. North America Unfractionated Heparin Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Unfractionated Heparin Revenue Market Share by Country (2016-2021) Table 22. Europe Unfractionated Heparin Sales by Country (2016-2021) & (K MT) Table 23. Europe Unfractionated Heparin Sales Market Share by Country (2016-2021) Table 24. Europe Unfractionated Heparin Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Unfractionated Heparin Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Unfractionated Heparin Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Unfractionated Heparin Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Unfractionated Heparin Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Unfractionated Heparin Revenue Market Share by Region (2016-2021) Table 30. Latin America Unfractionated Heparin Sales by Country (2016-2021) & (K MT) Table 31. Latin America Unfractionated Heparin Sales Market Share by Country (2016-2021) Table 32. Latin America Unfractionated Heparin Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Unfractionated Heparin Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Unfractionated Heparin Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Unfractionated Heparin Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Unfractionated Heparin Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Unfractionated Heparin Revenue Market Share by Country (2016-2021) Table 38. Global Unfractionated Heparin Sales (K MT) by Type (2016-2021) Table 39. Global Unfractionated Heparin Sales Market Share by Type (2016-2021) Table 40. Global Unfractionated Heparin Revenue (Million US$) by Type (2016-2021) Table 41. Global Unfractionated Heparin Revenue Share by Type (2016-2021) Table 42. Global Unfractionated Heparin Price (USD/MT) by Type (2016-2021) Table 43. Global Unfractionated Heparin Sales (K MT) by Application (2016-2021) Table 44. Global Unfractionated Heparin Sales Market Share by Application (2016-2021) Table 45. Global Unfractionated Heparin Revenue (Million US$) by Application (2016-2021) Table 46. Global Unfractionated Heparin Revenue Share by Application (2016-2021) Table 47. Global Unfractionated Heparin Price (USD/MT) by Application (2016-2021) Table 48. Baxter International Inc. Corporation Information Table 49. Baxter International Inc. Description and Business Overview Table 50. Baxter International Inc. Unfractionated Heparin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Baxter International Inc. Unfractionated Heparin Product Table 52. Baxter International Inc. Recent Developments/Updates Table 53. B. Braun Melsungen AG Corporation Information Table 54. B. Braun Melsungen AG Description and Business Overview Table 55. B. Braun Melsungen AG Unfractionated Heparin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. B. Braun Melsungen AG Unfractionated Heparin Product Table 57. B. Braun Melsungen AG Recent Developments/Updates Table 58. Fresenius SE & Co. KGaA Corporation Information Table 59. Fresenius SE & Co. KGaA Description and Business Overview Table 60. Fresenius SE & Co. KGaA Unfractionated Heparin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Fresenius SE & Co. KGaA Unfractionated Heparin Product Table 62. Fresenius SE & Co. KGaA Recent Developments/Updates Table 63. LEO Pharma A/S Corporation Information Table 64. LEO Pharma A/S Description and Business Overview Table 65. LEO Pharma A/S Unfractionated Heparin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. LEO Pharma A/S Unfractionated Heparin Product Table 67. LEO Pharma A/S Recent Developments/Updates Table 68. Sagent Pharmaceuticals Corporation Information Table 69. Sagent Pharmaceuticals Description and Business Overview Table 70. Sagent Pharmaceuticals Unfractionated Heparin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Sagent Pharmaceuticals Unfractionated Heparin Product Table 72. Sagent Pharmaceuticals Recent Developments/Updates Table 73. Pfizer, Inc. Corporation Information Table 74. Pfizer, Inc. Description and Business Overview Table 75. Pfizer, Inc. Unfractionated Heparin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Pfizer, Inc. Unfractionated Heparin Product Table 77. Pfizer, Inc. Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Unfractionated Heparin Distributors List Table 81. Unfractionated Heparin Customers List Table 82. Unfractionated Heparin Market Trends Table 83. Unfractionated Heparin Growth Drivers Table 84. Unfractionated Heparin Market Restraints Table 85. Global Unfractionated Heparin Sales Forecast by Type (2022-2027) & (K MT) Table 86. Global Unfractionated Heparin Sales Market Share Forecast by Type (2022-2027) Table 87. Global Unfractionated Heparin Revenue Forecast by Type (2022-2027) & (US$ Million) Table 88. Global Unfractionated Heparin Revenue Market Share Forecast by Type (2022-2027) Table 89. Global Unfractionated Heparin Sales Forecast by Application (2022-2027) & (K MT) Table 90. Global Unfractionated Heparin Sales Market Share Forecast by Application (2022-2027) Table 91. Global Unfractionated Heparin Revenue Forecast by Application (2022-2027) & (US$ Million) Table 92. Global Unfractionated Heparin Revenue Market Share Forecast by Application (2022-2027) Table 93. Global Unfractionated Heparin Sales Forecast by Region (2022-2027) & (K MT) Table 94. Global Unfractionated Heparin Sales Market Share Forecast by Region (2022-2027) Table 95. Global Unfractionated Heparin Revenue Forecast by Region (2022-2027) & (US$ Million) Table 96. Global Unfractionated Heparin Revenue Market Share Forecast by Region (2022-2027) Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Unfractionated Heparin Figure 2. Global Unfractionated Heparin Market Share by Type in 2020 & 2027 Figure 3. Bovine Product Picture Figure 4. Porcine Product Picture Figure 5. Global Unfractionated Heparin Market Share by Application in 2020 & 2027 Figure 6. Hospitals Figure 7. Clinics Figure 8. Other Figure 9. Global Unfractionated Heparin Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Unfractionated Heparin Market Size 2016-2027 (US$ Million) Figure 11. Global Unfractionated Heparin Sales 2016-2027 (K MT) Figure 12. Global Unfractionated Heparin Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Unfractionated Heparin Sales Share by Manufacturers in 2020 Figure 14. Global Unfractionated Heparin Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Unfractionated Heparin Players: Market Share by Revenue in 2020 Figure 16. Unfractionated Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Unfractionated Heparin Sales Market Share by Region (2016-2021) Figure 18. Global Unfractionated Heparin Sales Market Share by Region in 2020 Figure 19. Global Unfractionated Heparin Revenue Market Share by Region (2016-2021) Figure 20. Global Unfractionated Heparin Revenue Market Share by Region in 2020 Figure 21. U.S. Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Unfractionated Heparin Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Unfractionated Heparin by Type (2016-2021) Figure 46. Sales Market Share of Unfractionated Heparin by Application (2016-2021) Figure 47. Sales Market Share of Unfractionated Heparin by Application in 2020 Figure 48. Revenue Share of Unfractionated Heparin by Application (2016-2021) Figure 49. Revenue Share of Unfractionated Heparin by Application in 2020 Figure 50. Manufacturing Cost Structure of Unfractionated Heparin Figure 51. Manufacturing Process Analysis of Unfractionated Heparin Figure 52. Unfractionated Heparin Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Baxter International Inc. B. Braun Melsungen AG Fresenius SE & Co. KGaA LEO Pharma A/S Sagent Pharmaceuticals Pfizer, Inc.